CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-06-11 | KOZARICH JOHN W Director | Grant or award · Non-Qualified Stock Option (right to buy) | +7,335 | $32.30 | $237K | 7,335 |
| 2013-06-11 | Davis Todd C Director | Grant or award | +2,925 | 38,643 | ||
| 2013-06-11 | Davis Todd C Director | Grant or award | +1,393 | 40,036 | ||
| 2013-06-11 | Davis Todd C Director | Grant or award · Non-Qualified Stock Option (right to buy) | +7,335 | $32.30 | $237K | 7,335 |
| 2013-06-11 | Aryeh Jason Director | Grant or award | +2,925 | 31,243 | ||
| 2013-06-11 | Aryeh Jason Director | Grant or award · Non-Qualified Stock Option (right to buy) | +7,335 | $32.30 | $237K | 7,335 |
| 2013-06-03 | HIGGINS JOHN L President & CEO | Grant or award | +12,000 | 120,025 | ||
| 2013-06-03 | HIGGINS JOHN L President & CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +14,334 | $32.00 | $459K | 14,334 |
| 2013-06-03 | FOEHR MATTHEW W EVP and COO | Grant or award | +8,333 | 43,870 | ||
| 2013-05-10 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −4,000 | $26.66 | $107K | 12,829 |
| 2013-02-15 | Berkman Charles S VP, Gen. Counsel & Secretary | Grant or award | +2,500 | 16,829 | ||
| 2013-02-15 | Berkman Charles S VP, Gen. Counsel & Secretary | Grant or award · Employee Stock Option (right to buy) | +4,856 | $21.92 | $106K | 4,856 |
| 2013-02-15 | Berkman Charles S VP, Gen. Counsel & Secretary | Grant or award · Non-Qualified Stock Option (right to buy) | +15,144 | $21.92 | $332K | 15,144 |
| 2013-02-15 | DeSilva Nishan M VP, Corporate Development | Grant or award | +5,000 | 15,490 | ||
| 2013-02-15 | DeSilva Nishan M VP, Corporate Development | Grant or award · Incentive Stock Option (right to buy) | +4,374 | $21.92 | $96K | 4,374 |
| 2013-02-15 | DeSilva Nishan M VP, Corporate Development | Grant or award · Non-Qualified Stock Option (right to buy) | +40,626 | $21.92 | $891K | 40,626 |
| 2013-02-15 | Sharp John P VP Finance and CFO | Grant or award | +2,500 | 24,166 | ||
| 2013-02-15 | Sharp John P VP Finance and CFO | Grant or award · Incentive Stock Option (right to buy) | +4,432 | $21.92 | $97K | 4,432 |
| 2013-02-15 | Sharp John P VP Finance and CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +15,568 | $21.92 | $341K | 15,568 |
| 2013-02-15 | FOEHR MATTHEW W EVP and COO | Grant or award | +6,000 | 43,870 |
Page 84 of 86 · 1,712 trades